A peer-reviewed, fully open-access journal publishing original research and authoritative reviews at the convergence of molecular biology, pharmacology, and computational science.
JMTP publishes across eight interconnected domains that define modern therapeutic science.
Target validation, high-throughput screening, computational docking, and mechanistic pharmacology from molecule to phenotype.
Signal transduction, gene regulation, network-level mechanisms, and the systems-level logic of disease.
CAR-T/NK cell therapies, checkpoint biology, tumor microenvironment, and immunometabolism.
Genomics, proteomics, metabolomics, spatial transcriptomics, and integrative multi-omics in disease and therapy.
Machine learning for drug repurposing, deep learning in bioimage analysis, and AI-integrated clinical decision models.
Genetic determinants of drug response, pharmacokinetic modeling, biomarker development, and patient stratification.
Nanoparticle-based delivery, exosome engineering, targeted therapy, and biomaterial-based formulations.
Phase I/II trial biomarker studies, translational endpoints, real-world evidence, and early clinical pharmacology.
JMTP welcomes submissions across seven article formats, each with defined scope and limits.
JMTP offers a rigorous yet rapid review process. Authors receive first editorial decisions within 30 days.
The Journal of Molecular Therapeutics and Pharmacy (JMTP) is a peer-reviewed, fully open-access journal that publishes original research and authoritative reviews at the convergence of molecular biology, pharmacology, and computational science. JMTP advances the discovery, development, and translation of new therapies by bringing mechanistic biology, drug science, and data-driven discovery together in a single venue.
JMTP aims to become a high-impact reference journal for researchers who work at the interfaces of biology and medicine. The journal bridges the gap between fundamental molecular discoveries and their application in clinical or translational contexts. It gives equal weight to experimental rigor, computational depth, and therapeutic relevance.
JMTP gives priority to manuscripts that satisfy at least three of the following criteria:
JMTP does not publish descriptive studies that lack a mechanistic hypothesis, case reports without translational framing, studies with insufficient sample sizes or statistical power, manuscripts that replicate published findings without substantial conceptual advance, or review articles that summarize rather than critically synthesize existing literature.
JMTP depends on the expertise and judgment of its reviewer community. We value rigorous, constructive, and timely reviews that help authors improve their work. Below are the expectations and process for JMTP reviewers.
Reviewers receive an invitation email from the editorial management system. Before accepting, reviewers must confirm that they have no competing financial, professional, or personal interests with the authors or institutions listed on the manuscript.
Reviewers are expected to respond to invitations within five business days. If you are unable to review, please suggest two or three alternative experts in the field. JMTP maintains reviewer anonymity unless the reviewer opts into transparent peer review.
The standard review period is 21 days from the date of manuscript access. Extensions of up to 7 days may be requested via the editorial portal. JMTP tracks reviewer performance and uses it to prioritize future invitations.
Reviews should address: (a) significance and novelty of the findings; (b) rigor of experimental design and controls; (c) appropriateness of statistical methods; (d) clarity and completeness of the Methods section; and (e) data availability and reproducibility. Numbered comments are required. A summary paragraph intended for the authors is recommended.
Manuscripts under review are strictly confidential. Reviewers must not share, cite, or use any information from an unpublished manuscript without explicit written permission from the corresponding author. Reviewers must not upload manuscripts to any AI language model or cloud processing platform.
JMTP acknowledges all reviewers annually in a published Reviewer Acknowledgment list. Reviewers who complete three or more reviews in a calendar year are eligible for a complimentary editorial board nomination and a certificate of appreciation. Reviewer performance data is shared with Publons/Web of Science Reviewer Recognition upon request.
Expertise: [Primary research areas]. [Brief statement about vision for the journal.]
JMTP uses an online submission and peer-review management system. All submissions, revisions, and correspondence are handled through the portal. Before submitting, please review the .
Main manuscript (Word .docx, double-spaced, line-numbered). Figures as separate TIFF/EPS files at ≥ 300 dpi. Supplementary materials as a single PDF. Cover letter and conflict of interest statement.
Use the JMTP submission portal. All authors must be registered. The corresponding author manages submission and is responsible for correspondence throughout review.
Enter title, abstract, keywords (5–8 terms), article type, and suggested reviewers (3–5 names with institutional emails). Declare any conflicts of interest and any prior preprint posting.
Upload all files, confirm the author list and order, and click Submit. You will receive an automated acknowledgment with a manuscript tracking number within 24 hours.
Log in to the portal at any time to track the status of your submission. JMTP aims to provide an editorial decision within 30 days of submission. Queries may be sent to editorial@jmtp.jsbpublishers.com after 35 days without response.
New submissions and revisions are accepted year-round through the manuscript portal.